Two hotspot mutations at −124 and −146 positions from the ATG start site in the TERT promoter have been shown to regulate TERT expression or the telomerase activation of human malignancies, including HCC [6,7]. The gene discussed is TERT; the disease is hepatocellular carcinoma.